Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mediwound Ltd Ord Sh
(NQ:
MDWD
)
20.10
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mediwound Ltd Ord Sh
< Previous
1
2
3
4
5
Next >
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 05, 2024
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family
Via
Benzinga
US Stocks Mixed; Jobs Figures Top Estimates For June
July 05, 2024
Via
Benzinga
Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
July 05, 2024
Shares of Sharps Technology, Inc. (NASDAQ:STSS) rose sharply in today's pre-market trading after the company announced it received two purchase orders for a total of approximately one million...
Via
Benzinga
Preview: MediWound's Earnings
March 20, 2024
Via
Benzinga
Recap: MediWound Q3 Earnings
November 21, 2023
Via
Benzinga
Earnings Outlook For MediWound
November 20, 2023
Via
Benzinga
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q1 2024
May 29, 2024
MDWD stock results show that MediWound beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
May 29, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report First Quarter 2024 Financial Results
May 22, 2024
Conference Call and Webcast Scheduled for Wednesday, May 29th at 8:30 am Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
April 25, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Ltd. (NASDAQ: MDWD) Sets New 52-Week High in Wednesday Session
April 17, 2024
Via
Investor Brand Network
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023
March 21, 2024
MDWD stock results show that MediWound beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
March 21, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
Conference Call and Webcast Scheduled for Thursday, March 21st at 8:30 am Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For March 21, 2024
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
February 12, 2024
Results demonstrate superiority of EscharEx®, a bromelain-based gel vs. SANTYL®, a collagenase ointment, in wound debridement, promotion of granulation tissue, and time to wound closure in patients...
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Participate in Two Upcoming Investor Conferences
February 05, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns
January 09, 2024
From
MediWound Ltd.
Via
GlobeNewswire
Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development
December 28, 2023
Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S.
Via
Benzinga
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army
December 28, 2023
Awarded additional $6.7 million to advance NexoBrid as a non-surgical field care solution; R&D project budget increased to $14.4 million
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
December 21, 2023
Results show EscharEx to be safe and effective, and suggest it can go beyond traditional expectations for enzymatic debridement
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For November 21, 2023
November 21, 2023
Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is likely to report quarterly earnings at $0.11 per share on revenue of $149.42 million.
Via
Benzinga
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update
November 21, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
November 21, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Third Quarter 2023 Financial Results
November 14, 2023
Conference Call and Webcast Scheduled for Tuesday, November 21st at 8:30 am Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients
November 13, 2023
The label expansion will solidify NexoBrid’s position in the EU as a safe and effective non-surgical treatment for burn patients of all ages
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe
November 08, 2023
NexoBrid complements PMI’s portfolio, allowing it to provide a comprehensive solution for burn patients
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Collaboration with 3M on EscharEx® Phase III Study
October 11, 2023
MediWound to join forces with 3M Health Care, world’s largest wound care company in pivotal study for patients with venous leg ulcers
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Deploys NexoBrid® for Emergency Supply
October 09, 2023
From
MediWound Ltd.
Via
GlobeNewswire
Q4 Stock Predictions: 3 Micro-Cap Stocks Ready to Skyrocket Into 2024
October 03, 2023
These Q4 micro-cap stocks are the ones to buy in on for long-term growth and returns to any investor's portfolio.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.